Catheter Precision (VTAK) Amortization of Deferred Charges (2025 - 2026)
Catheter Precision's (VTAK) quarterly Amortization of Deferred Charges came in at $97000.0 in Q1 2026, up 321.74% year-on-year from $23000.0 in Q1 2025, and up 438.89% on a QoQ basis from $18000.0 in Q4 2025.
Catheter Precision (VTAK) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
Catheter Precision (VTAK) has 2 years of Amortization of Deferred Charges data on file, last reported at $97000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 321.74% year-over-year to $97000.0 in Q1 2026; TTM through Mar 2026 was $119000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $45000.0, changed N/A from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $97000.0, up from $18000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for VTAK reached as high as $97000.0 in Q1 2026 and fell as low as -$13000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Catheter Precision | 610,863.29 | 210,863.29 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97,000.00 |
| Mar 31, 2026 | 97,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |